Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M).
S R AravindKiran P SinghGrace AquitaniaLiliia MogylnytskaAlsu G ZalevskayaBeata Matyjaszek-MatuszekKarin Wernicke-PantenMy-Liên Nguyên-PascalSuzanne PierreBaerbel RotthaeuserDaniel KramerBhaswati MukherjeePublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
EudraCT number 2017-000092-84.